Zilxi Generic Name & Formulations
Minocycline (as HCl) 1.5%; foam; contains alcohol.
Inflammatory lesions of rosacea.
Limitations of Use
Not been evaluated in the treatment of infections.
Zilxi Dosage and Administration
Apply at the same time each day ≥1hr before bedtime. Apply a thin layer onto affected area(s) of the face; repeat as needed. Avoid bathing, showering or swimming for ≥1hr after application.
Zilxi Boxed Warnings
Not for oral, ophthalmic, or intravaginal use. Monitor for visual disturbances prior to initiation. History of intracranial hypertension. Overweight women. Avoid sunlight or UV light; discontinue at 1st sign of sunburn. Discontinue if serious skin reactions (eg, Stevens Johnson syndrome, erythema multiforme, DRESS syndrome) or superinfection develop. Hepatic or renal impairment. Product is flammable. Pregnancy. Nursing mothers: not recommended.
Avoid concomitant penicillins, isotretinoin. May need to reduce concomitant anticoagulant dose. May interfere with fluorescence test.
Zilxi Adverse Reactions
Diarrhea; teeth discoloration, delayed skeletal development, intracranial hypertension, CNS effects, C. difficile-associated diarrhea, increased BUN, hepatotoxicity, renal toxicity, photosensitivity, skin/hypersensitivity reactions (may be severe), hyperpigmentation, autoimmune syndromes (eg, lupus-like syndrome, serum sickness; discontinue if symptoms occur).
Zilxi Clinical Trials
Zilxi Patient Counseling